Buy Antibiotics Online

BANGALORE, Dec 5 (Reuters) - Shares of Targanta Therapeutics Corp rose as much as 86 percent on Friday, ahead of a key regulatory meeting on Monday that would decide the fate of the company's experimental skin-infection antibiotic, oritavancin.
'There is a little bit of speculation that at the current price, downside is limited, but there is a lot of upside if the Food and Drug Administration does give them a positive (nod),' Cowen & Co analyst Ian Sanderson told Reuters.
The company had in September submitted oritavancin for approval as a treatment for complicated skin infections from a variety Continue reading

Release Date: December 8, 2008
Valid for credit through December 8, 2009
To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate
.
The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label Continue reading

—
Q: Hey Doc, my wife went to the dentist the other day for a cleaning and was told she needed to take an antibiotic because she had a knee replacement. We never heard anything about this and she was too embarrassed to ask. Is this common? What should she do?
A: It is extremely common. Unfortunately, recent changes to the guidelines regarding the use of antibiotic prior to dental treatment have made it very confusing for patients and practitioners alike. Many people who in the past have always taken antibiotics prior to dental treatment are now being told it is no longer necessary. The same Continue reading

Tuesday, December 09, 2008
About 300 babies in Australia have been exposed to tuberculosis from an infected doctor.
Health officials said the children in the neo-natal intensive care unit and the special care baby unit of Adelaide's Women's and Children's Hospital may have come into "close and prolonged contact" with an infected doctor.
About 75 of these children are too young to diagnose, and will be treated with antibiotics to minimize the chances of infection.
The doctor was screened for TB by immigration authorities when he arrived in Australia in March this year. His chest X-ray found Continue reading

How many times have you dismissed sniffles as "just a cold," and carried on with a stuffed nose and sinuses assuming that the symptoms would eventually run their course, perhaps a bit more quickly with a few doses of Mom's homemade chicken soup?
Influenza is another story. The common cold eventually fizzles, but the flu may be deadly. Some
that claimed between 20 and 100 million lives. The best defense against it: a
. Yet barely 30 percent of 4,000 U.S. adults surveyed said they'd been inoculated this season, despite a
, according to a new
. (GlaxoSmithKline, which makes flu vaccine, Continue reading

ScienceDaily (Dec. 8, 2008)
— Antibiotics are the single largest class of agents that cause idiosyncratic drug-induced liver injury (DILI), reports a new study in Gastroenterology, an official journal of the American Gastroenterological Association (AGA) Institute. DILI is the most common cause of death from acute liver failure and accounts for approximately 13 percent of cases of acute liver failure in the U.S.
It is caused by a wide variety of prescription and nonprescription medications, nutritional supplements and herbals.
"DILI is a serious health problem that impacts patients, Continue reading

NEW YORK (Associated Press) - Shares of Cubist Pharmaceuticals Inc. sank Monday as concerns swirled about the patent protection for its antibiotic Cubicin, which provides almost all of the company's revenue.
Leerink Swann analyst Howard Liang lowered his rating to "Underperform" from "Market Perform" because of his view that investors are overlooking the risk that a generic drug maker will challenge the patents protecting Cubicin. He said Cubist shares might be worth $10 if the patents were successfully challenged.
Shares of the Lexington, Mass., company fell $2.34, or 8.7 percent, to $24.64 Continue reading

This press release contains forward-looking statements made pursuant
to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995 that involve risks and that could cause PolyMedix's
actual results and experience to differ materially from anticipated
results and expectations expressed in these forward looking statements.
PolyMedix has in some cases identified forward-looking statements by
using words such as "anticipates," "believes," "hopes," "estimates,"
"looks," "expects," "plans," "intends", "goal", "potential," Continue reading